As of 21 Sept 2026, Advanced Enzyme Technologies Ltd share price is ₹288.15. The stock opened at ₹288.15 and had closed at ₹288.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹251.90 and a high of ₹419.80. In terms of performance, Advanced Enzyme Technologies Ltd share price has increased by 5.76% over the past six months and has decreased by 14.80% over the last year.
ADVENZYMES Stock Price Chart
Advanced Enzyme Technologies Ltd Overview
About ADVENZYMES
Advanced Enzyme Techs. engaged in the business of manufacturing and sales of enzymes.
Advanced Enzyme Technologies Ltd Historical Performance
Advanced Enzyme Technologies Ltd Fundamentals
Advanced Enzyme Technologies Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 516.16 | 412.90 | 424.28 | 321.34 | 281.88 |
| EBITDA | 169.96 | 132.18 | 145.05 | 84.70 | 81.73 |
| Net Profit | 131.81 | 102.42 | 108.12 | 55.53 | 54.51 |
| EPS | 11.78 | 9.16 | 9.67 | 4.97 | 4.88 |
Advanced Enzyme Technologies Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 284.77 |
| Resistance 1 (R1) | 291.62 |
| Pivot Point | 288.38 |
Advanced Enzyme Technologies Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 24-Jul-2026 | 09-May-2026 | 24-Jul-2026 | Final | ₹1.35 |
| 23-Jul-2025 | 13-May-2025 | 23-Jul-2025 | Final | ₹1.20 |
| 16-May-2025 | 13-May-2025 | 17-May-2025 | Interim | ₹4.00 |
| 18-Jul-2024 | 11-May-2024 | 18-Jul-2024 | Final | ₹1.10 |
| 17-May-2024 | 11-May-2024 | 18-May-2024 | Interim | ₹4.00 |
ADVENZYMES Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| VASANT RATHI | Chairman |
| MUKUND MADHUSUDAN KABRA | E D & Wholetime Directorector |
| Rasika Rathi | Non Executive Independent Director |
Advanced Enzyme Technologies Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,837.30-1.61% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,375.00+0.56% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,840.00-0.72% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Advanced Enzyme Technologies Ltd today is ₹288.15 on NSE and ₹288.15 on BSE.
- The 52-week high of Advanced Enzyme Technologies Ltd is ₹419.80, while the 52-week low is ₹251.90.
- The current market capitalisation of Advanced Enzyme Technologies Ltd is approximately ₹3,227 crore.
- The P/E (Price-to-Earnings) ratio of Advanced Enzyme Technologies Ltd is 20.51. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Advanced Enzyme Technologies Ltd is 2.14. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Advanced Enzyme Technologies Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ADVENZYMES on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Advanced Enzyme Technologies Ltd has delivered a return of approximately -8.06%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Advanced Enzyme Technologies Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 43.24% promoters, 24.89% FIIs, 4.78% DIIs, and 16.94% public shareholders.

